Moshe H. Erder

731 total citations
18 papers, 570 citations indexed

About

Moshe H. Erder is a scholar working on Oncology, Surgery and Hematology. According to data from OpenAlex, Moshe H. Erder has authored 18 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Surgery and 4 papers in Hematology. Recurrent topics in Moshe H. Erder's work include Diverticular Disease and Complications (5 papers), Blood disorders and treatments (4 papers) and Neutropenia and Cancer Infections (4 papers). Moshe H. Erder is often cited by papers focused on Diverticular Disease and Complications (5 papers), Blood disorders and treatments (4 papers) and Neutropenia and Cancer Infections (4 papers). Moshe H. Erder collaborates with scholars based in United States and United Kingdom. Moshe H. Erder's co-authors include Moshe Fridman, Joel Kallich, Jeffrey H. Silber, Robert S. DiPaola, Kevin R. Fox, Mark V. Pauly, N. Simon Tchekmedyian, Anne M. McDermott, Peter Fayers and Gabriel N. Hortobágyi and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer.

In The Last Decade

Moshe H. Erder

17 papers receiving 537 citations

Peers

Moshe H. Erder
AH Partridge United States
Moon Hee Lee South Korea
Kim Jordan United States
Anna Moseley United States
Nehal Masood Pakistan
Kristen McCullough United States
J M Cruz United States
K Malottki United Kingdom
Peter Nieboer Netherlands
E. Mayer United States
AH Partridge United States
Moshe H. Erder
Citations per year, relative to Moshe H. Erder Moshe H. Erder (= 1×) peers AH Partridge

Countries citing papers authored by Moshe H. Erder

Since Specialization
Citations

This map shows the geographic impact of Moshe H. Erder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe H. Erder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe H. Erder more than expected).

Fields of papers citing papers by Moshe H. Erder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moshe H. Erder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe H. Erder. The network helps show where Moshe H. Erder may publish in the future.

Co-authorship network of co-authors of Moshe H. Erder

This figure shows the co-authorship network connecting the top 25 collaborators of Moshe H. Erder. A scholar is included among the top collaborators of Moshe H. Erder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moshe H. Erder. Moshe H. Erder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fuller, Garth, Roger Bolus, Jennifer Talley, et al.. (2014). Mo1131 Development and Validation of Prism: A Patient Reported Outcome Measure for GERD Patients Who Are Partial or Non-Responders to PPI Therapy. Gastroenterology. 146(5). S–565. 2 indexed citations
2.
Spiegel, Brennan, Mark W. Reid, Roger Bolus, et al.. (2014). 1051 Development and Validation of a Disease-Targeted Quality of Life Instrument for Chronic Diverticular Disease: the DV-QOL. Gastroenterology. 146(5). S–186. 5 indexed citations
3.
Cohen, Erica, Garth Fuller, Roger Bolus, et al.. (2012). Tu1363 Evidence for Post-Diverticulitis Irritable Bowel Syndrome (Pdv-IBS): Longitudinal Analysis Reveals Higher Incidence of IBS in DV Cases vs. Controls. Gastroenterology. 142(5). S–811. 7 indexed citations
4.
Shahedi, Kamyar, Garth Fuller, Roger Bolus, et al.. (2012). 847 Progression From Incidental Diverticulosis to Acute Diverticulitis. Gastroenterology. 142(5). S–144. 14 indexed citations
5.
Vu, Michelle, Garth Fuller, Roger Bolus, et al.. (2012). Mo1036 Post Diverticulitis (DV) Depression: Longitudinal Analysis Reveals Higher Incidence in Cases vs. Controls. Gastroenterology. 142(5). S–578. 1 indexed citations
6.
Kawatkar, Aniket A., George F. Longstreth, Linnette Yen, et al.. (2012). Su1204 Predictors of Recurrence of Acute Diverticulitis in an Incident Diverticulitis Cohort. Gastroenterology. 142(5). S–450.
7.
Lyman, Gary H., Ernst R. Berndt, Joel Kallich, et al.. (2005). The Economic Burden of Anemia in Cancer Patients Receiving Chemotherapy. Value in Health. 8(2). 149–156. 58 indexed citations
8.
9.
Rivera, Edgardo, et al.. (2003). Targeted filgrastim support in patients with early‐stage breast carcinoma. Cancer. 98(2). 222–228. 20 indexed citations
10.
Tchekmedyian, N. Simon, Joel Kallich, Anne M. McDermott, Peter Fayers, & Moshe H. Erder. (2003). The relationship between psychologic distress and cancer‐related fatigue. Cancer. 98(1). 198–203. 65 indexed citations
11.
Rivera, Edgardo, Moshe H. Erder, Moshe Fridman, Debra Frye, & Gabriel N. Hortobágyi. (2003). First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study. Breast Cancer Research. 5(5). R114–20. 42 indexed citations
12.
Erder, Moshe H., Nancy C. Santanello, & Ron D. Hays. (2003). Assessing the clinical significance of patient-reported outcomes: Examples drawn from a recent meeting of the drug information association (DIA). Clinical Therapeutics. 25. D12–D13. 5 indexed citations
13.
Lu, Zhanni, et al.. (2002). Economic Analysis of Filgrastim Use for Patients with Acute Myeloid Leukaemia in the UK. PharmacoEconomics. 20(10). 665–674. 5 indexed citations
14.
Kallich, Joel, N. Simon Tchekmedyian, Anne M. Damiano, et al.. (2002). Psychological outcomes associated with anemia-related fatigue in cancer patients.. PubMed. 16(9 Suppl 10). 117–24. 44 indexed citations
15.
Glick, Henry A., Elizabeth J. Shpall, C.F. LeMaistre, et al.. (1998). Empirical Criteria for the Selection of Quality-of-Life Instruments for the Evaluation of Peripheral Blood Progenitor Cell Transplantation. International Journal of Technology Assessment in Health Care. 14(3). 419–430. 3 indexed citations
16.
Silber, Jeffrey H., Moshe Fridman, Robert S. DiPaola, et al.. (1998). First-cycle blood counts and subsequent neutropenia, dose reduction, or delay in early-stage breast cancer therapy.. Journal of Clinical Oncology. 16(7). 2392–2400. 123 indexed citations
17.
18.
Willke, Richard J., et al.. (1997). Quality of Life Effects of Alprostadil Therapy for Erectile Dysfunction. The Journal of Urology. 157(6). 2124–2128. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by AH Partridge Breakdown of academic impact, for papers by Moon Hee Lee Breakdown of academic impact, for papers by Kim Jordan Breakdown of academic impact, for papers by Anna Moseley Breakdown of academic impact, for papers by Nehal Masood Breakdown of academic impact, for papers by Kristen McCullough Breakdown of academic impact, for papers by J M Cruz Breakdown of academic impact, for papers by K Malottki Breakdown of academic impact, for papers by Peter Nieboer Breakdown of academic impact, for papers by E. Mayer
Rankless by CCL
2026